19
views
0
recommends
+1 Recommend
0 collections
    0
    shares
      • Record: found
      • Abstract: found
      • Article: found
      Is Open Access

      Synthesis of Novel Selenocyanates and Evaluation of Their Effect in Cultured Mouse Neurons Submitted to Oxidative Stress

      research-article

      Read this article at

      Bookmark
          There is no author summary for this article yet. Authors can add summaries to their articles on ScienceOpen to make them more accessible to a non-specialist audience.

          Abstract

          Herein, we report the synthesis of novel selenocyanates and assessment of their effect on the oxidative challenge elicited by hydrogen peroxide (H 2O 2) in cultured mouse neurons. First, α-methylene- β-hydroxy esters were prepared as precursors of allylic bromides. A reaction involving the generated bromides and sodium selenocyanate was conducted to produce the desired selenocyanates (3a-f). We next prepared cultures of neurons from 7-day-old mice ( n = 36). H 2O 2 (10 −5 M) was added into the culture flasks as an oxidative stress inducer, alone or combined with one of each designed compounds. (PhSe) 2 was used as a positive control. It was carried out assessment of lipid (thiobarbituric acid reactive species, 4-hydroxy-2′-nonenal, 8-isoprostane), DNA (8-hydroxy-2′-deoxyguanosine), and protein (carbonyl) modification parameters. Finally, catalase and superoxide dismutase activities were also evaluated. Among the compounds, 3b, 3d, and 3f exhibited the most pronounced pattern of antioxidant activity, similar to (PhSe) 2. These novel aromatic selenocyanates could be promising to be tried in most sophisticated in vitro studies or even at the preclinical level.

          Related collections

          Most cited references64

          • Record: found
          • Abstract: found
          • Article: not found

          Structure of Mpro from COVID-19 virus and discovery of its inhibitors

          A new coronavirus, known as severe acute respiratory syndrome coronavirus 2 (SARS-CoV-2), is the aetiological agent responsible for the 2019-2020 viral pneumonia outbreak of coronavirus disease 2019 (COVID-19)1-4. Currently, there are no targeted therapeutic agents for the treatment of this disease, and effective treatment options remain very limited. Here we describe the results of a programme that aimed to rapidly discover lead compounds for clinical use, by combining structure-assisted drug design, virtual drug screening and high-throughput screening. This programme focused on identifying drug leads that target main protease (Mpro) of SARS-CoV-2: Mpro is a key enzyme of coronaviruses and has a pivotal role in mediating viral replication and transcription, making it an attractive drug target for SARS-CoV-25,6. We identified a mechanism-based inhibitor (N3) by computer-aided drug design, and then determined the crystal structure of Mpro of SARS-CoV-2 in complex with this compound. Through a combination of structure-based virtual and high-throughput screening, we assayed more than 10,000 compounds-including approved drugs, drug candidates in clinical trials and other pharmacologically active compounds-as inhibitors of Mpro. Six of these compounds inhibited Mpro, showing half-maximal inhibitory concentration values that ranged from 0.67 to 21.4 μM. One of these compounds (ebselen) also exhibited promising antiviral activity in cell-based assays. Our results demonstrate the efficacy of our screening strategy, which can lead to the rapid discovery of drug leads with clinical potential in response to new infectious diseases for which no specific drugs or vaccines are available.
            Bookmark
            • Record: found
            • Abstract: not found
            • Book Chapter: not found

            [13] Catalase in vitro

            Hugo Aebi (1984)
              Bookmark
              • Record: found
              • Abstract: not found
              • Article: not found

              A simplification of the protein assay method of Lowry et al. which is more generally applicable.

                Bookmark

                Author and article information

                Contributors
                Journal
                Oxid Med Cell Longev
                Oxid Med Cell Longev
                OMCL
                Oxidative Medicine and Cellular Longevity
                Hindawi
                1942-0900
                1942-0994
                2020
                28 May 2020
                : 2020
                : 5417024
                Affiliations
                1Department of Energy and Sustainability, Federal University of Santa Catarina (UFSC), Araranguá, 88906-072 SC, Brazil
                2Translational Psychiatry Laboratory, Graduate Program in Health Sciences, University of Southern Santa Catarina (UNESC), Criciúma, 88806-000 SC, Brazil
                3Center for Natural and Human Sciences-CCNH, Federal University of ABC (UFABC), Santo André, 09210-580 SP, Brazil
                4Laboratory of Experimental Pathophysiology, Graduate Program in Health Sciences, Health Sciences Unit, University of Southern Santa Catarina (UNESC), Criciúma. 88806-000 SC, Brazil
                5Federal University of São Paulo (UNIFESP), São José dos Campos, 12231-280 SP, Brazil
                6Institute of Chemistry, Federal University of Mato Grosso do Sul (UFMS), Campo Grande, 79074-460 MS, Brazil
                Author notes

                Academic Editor: José P. Andrade

                Author information
                https://orcid.org/0000-0003-3803-3556
                https://orcid.org/0000-0002-6134-7249
                https://orcid.org/0000-0003-3003-8977
                https://orcid.org/0000-0002-7314-6946
                https://orcid.org/0000-0002-2336-040X
                Article
                10.1155/2020/5417024
                7275203
                33093936
                c1fa663f-ea2a-44fb-a935-2efaf3fc89d6
                Copyright © 2020 Tiago E. A. Frizon et al.

                This is an open access article distributed under the Creative Commons Attribution License, which permits unrestricted use, distribution, and reproduction in any medium, provided the original work is properly cited.

                History
                : 12 February 2020
                : 1 May 2020
                : 5 May 2020
                Funding
                Funded by: Federal University of Santa Catarina (UFSC)
                Funded by: Southern University of Santa Catarina (UNESC)
                Funded by: Research and Innovation Support Foundation of Santa Catarina State (FAPESC)
                Award ID: 2019TR1055
                Funded by: Federal University of Mato Grosso do Sul (UFMS)
                Funded by: Conselho Nacional de Desenvolvimento Científico e Tecnológico
                Award ID: 433896/2018-3
                Funded by: Coordenação de Aperfeiçoamento de Pessoal de Nível Superior
                Categories
                Research Article

                Molecular medicine
                Molecular medicine

                Comments

                Comment on this article

                scite_

                Similar content166

                Cited by12

                Most referenced authors1,073